Latest filing published 05 May 2025 for Willow Biosciences Inc., €6,925.
Donald Archibald discloses dealings in Willow Biosciences Inc. to SEDI. Between 12 April 2019 and 2 May 2025, the trades on record add up to 12 filings.
Purchases make up the whole of the open-market record (1 purchase, €48k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 option exercises.
The record was last updated on 5 May 2025 with an option exercise (€6,925) in Willow Biosciences Inc. The last insider purchase was made public on 7 September 2022, 1,509 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations